Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, disclosed the publication of a circular containing a notice of its decision to hold an extraordinary general meeting of shareholders to vote on the necessary matters relating to the acquisition of Dublin-based Shire plc.